Invesco Global Health Care Invstor
(GTHIX)
US Markets Closed
AdChoices
44.45
+0.46
+1.05%
:

Previous Close

43.99

Net Assets

682.88M

Yield

0.03%

Front load

None

Expenses

1.10%

Category

Health

Morningstar Risk

Average

Morningstar Rating ★★
AdChoices
Performance
Returns %
Key statistics
  • Composition
  • Performance
  • Top Holdings
  • Top Rated Funds
  • Fund vs. Category
Quarterly Returns
  • Annual

  • GTHIX

  • Category

    • 2013

    • 42.53%

    • -

    • 2012

    • 20.77%

    • -

    • 2011

    • 4.18%

    • -

    • 2010

    • 4.62%

    • -

    • 2013

    • 2012

    • 2011

      • Q1

      • 15.12%

      • 12.79%

      • 8.12%

      • Q2

      • 3.53%

      • -0.10%

      • 6.40%

      • Q3

      • 8.95%

      • 6.72%

      • -14.48%

      • Q4

      • 9.76%

      • 0.42%

      • 5.88%

      Composition
      Sector Weightings
      Equity Investment Style
      The two dimensions of the Fund Style box measure the average size of companies that have been in the FUND, from the top to bottom, and the average valuation characteristics of the FUND's past stock holdings, from left to right.
      • Name

      • % Portfolio Weight

      • Shares Held

      • Change

        • Sanofi ADR

        • 4.05

        • 1,243,725

        • 0

        • Roche Holding AG

        • 3.89

        • 214,814

        • 0

        • Novartis AG ADR

        • 3.87

        • 701,780

        • 0

        • Gilead Sciences Inc

        • 3.81

        • 753,020

        • -46,204

        • Pfizer Inc

        • 3.69

        • 2,039,989

        • 0

        • Biogen Idec Inc

        • 3.06

        • 157,754

        • 0

        • Alexion Pharmaceuticals Inc

        • 3.05

        • 317,150

        • 0

        • Bayer AG

        • 2.66

        • 312,053

        • 0

        • HCA Holdings Inc

        • 2.61

        • 770,750

        • 0

        • Celgene Corp

        • 2.59

        • 489,690

        • 0

        • Name

        • Rating

        • YTD Return %

          • Prudential Jennison Health Sciences A LW

          • ★★★★★
          • 15.57

          • VALIC Company I Health Sciences

          • ★★★★★
          • 16.58

          • Prudential Jennison Health Sciences Z

          • ★★★★★
          • 15.85

          • T. Rowe Price Health Sciences

          • ★★★★★
          • 16.85

          • BlackRock Health Sciences Opps Inv C

          • ★★★★
          • 14.54

          • Franklin Biotechnology Discovery A LW

          • ★★★★
          • 17.52

          • Vanguard Health Care Adm

          • ★★★★
          • 16.60

          • Fidelity Advisor® Biotechnology A LW

          • ★★★★
          • 17.10

          • Fidelity Advisor® Health Care A LW

          • ★★★★
          • 18.09

          • Janus Global Life Sciences I

          • ★★★★
          • 17.98

          • Name

          • GTHIX

          • Category

            • Expense Ratio

            • 1.10%

            • 1.45%

            • Net Assets

            • 682.88M

            • 711.24M

            • Dividend Yield

            • 1.05%

            • 0.61

            • Price/Book

            • 3.47

            • 4.82

            • Price/Sales

            • 1.67

            • 3.25

            • Price/Cash Flow

            • 14.45

            • 19.29

            Profile

            Name of Issuer

            Invesco

            Fund Style

            Open

            Fund Manager

            Derek Taner

            Investment Style

            Large Growth

            The investment seeks long-term growth of capital. The fund invests at least 80% of its net assets (plus any borrowings for investment purposes) in securities of issuers engaged primarily in health care-related industries, and in derivatives and other instruments that have economic characteristics similar to such securities. It invests primarily in equity securities, securities convertible into equity securities, and depositary receipts. The fund may invest in the securities of issuers of all capitalization sizes; however, the fund may invest a significant amount of its net assets in the securities of small- and mid-capitalization issuers.

            Purchase Information

            Initial Purchase 1,000
            Initial Purchase: IRA 250
            Initial Purchase: AIP 50
            Front load None
            Back Load None

            Inception

            7/15/2005